Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Pulmonary Hypertension

  Free Subscription


05.07.2021

1 Acta Biomed
1 Acta Clin Belg
1 Am J Cardiol
1 Am J Mens Health
1 Am J Physiol Heart Circ Physiol
1 Am J Respir Cell Mol Biol
2 Ann Am Thorac Soc
1 Arq Bras Cardiol
1 BMJ Case Rep
1 Cell Biochem Biophys
3 Cells
1 Chin J Physiol
1 Compr Physiol
1 Contact Dermatitis
1 Curr Opin Pulm Med
2 Diagnostics (Basel)
2 Echocardiography
1 Entropy (Basel)
5 ESC Heart Fail
1 Eur J Cardiothorac Surg
7 Eur Respir J
1 Front Cell Dev Biol
1 Front Vet Sci
1 Int J Cardiovasc Imaging
1 Int J Chron Obstruct Pulmon Dis
1 Int J Mol Sci
1 J Clin Med
1 J Clin Rheumatol
1 J Patient Rep Outcomes
1 J Pediatr
5 J Thorac Cardiovasc Surg
1 Kyobu Geka
1 Lancet Respir Med
1 N Engl J Med
1 Pharmacol Ther
3 Pulm Circ
1 Respir Care
1 Respir Med Res
1 Rev Port Cardiol
1 Rheumatol Int
1 Rheumatology (Oxford)
1 Semin Thorac Cardiovasc Surg
1 Vascul Pharmacol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Biomed

  1. KOORANIFAR S, Naghshin R, Sezavar SH, Hajsadeghi S, et al
    Diagnostic value of chest spiral CT scan and Doppler echocardiography compared to right heart catheterization to predict pulmonary arterial hypertension in patients with scleroderma.
    Acta Biomed. 2021;92:e2021074.
    PubMed         Abstract available


    Acta Clin Belg

  2. KATRIEN M, Dieter S, Anke D, Amelie D, et al
    Case report: pulmonary veno-occlusive disease: a rare but fatal cause of pulmonary hypertension in a patient following allogeneic stem cell transplantation.
    Acta Clin Belg. 2021 Jun 30:1-6. doi: 10.1080/17843286.2021.1945352.
    PubMed         Abstract available


    Am J Cardiol

  3. KHAN MZ, Zahid S, Khan MU, Kichloo A, et al
    Comparison of In-Hospital Outcomes of Transcatheter Mitral Valve Repair in Patients With vs Without Pulmonary Hypertension (From the National Inpatient Sample).
    Am J Cardiol. 2021 Jun 28. pii: S0002-9149(21)00496.
    PubMed         Abstract available


    Am J Mens Health

  4. LV ZC, Li F, Wang L, Zhao QH, et al
    Impact of Parthanatos on the Increased Risk of Onset and Mortality in Male Patients With Pulmonary Hypertension.
    Am J Mens Health. 2021;15:15579883211029458.
    PubMed         Abstract available


    Am J Physiol Heart Circ Physiol

  5. VU LD, Saravia J, Jaligama S, Baboeram Panday RV, et al
    Deficiency of ST2 signaling ameliorates RSV-associated pulmonary hypertension.
    Am J Physiol Heart Circ Physiol. 2021 Jun 25. doi: 10.1152/ajpheart.00018.2021.
    PubMed         Abstract available


    Am J Respir Cell Mol Biol

  6. SHARMA M, Rana U, Joshi C, Michalkiewicz T, et al
    Decreased Cyclic GMP-protein Kinase G signaling impairs Angiogenesis in a Lamb Model of Persistent Pulmonary Hypertension of Newborn.
    Am J Respir Cell Mol Biol. 2021 Jun 29. doi: 10.1165/rcmb.2020-0434.
    PubMed         Abstract available


    Ann Am Thorac Soc

  7. SAMANT S, Tran HV, Uddo RB, deBoisblanc BP, et al
    Use of Handheld Ultrasound to Estimate Right Atrial Pressure in a Pulmonary Hypertension Clinic.
    Ann Am Thorac Soc. 2021 Jul 2. doi: 10.1513/AnnalsATS.202101.
    PubMed         Abstract available

  8. ZENG X, Huang X, Rathinasabapathy A, Xu Z, et al
    Prevalence of Schistosoma japonicum-associated Pulmonary Hypertension in China: An Echocardiography-based Assessment.
    Ann Am Thorac Soc. 2021 Jun 28. doi: 10.1513/AnnalsATS.202012-1573.
    PubMed        


    Arq Bras Cardiol

  9. FARIAS LPG, Favaretto AC, Baptista LPS, Teles GBDS, et al
    Pulmonary Arterial Intramural Hematoma Due to Acute Aortic Dissection.
    Arq Bras Cardiol. 2021;116:1169-1171.
    PubMed        


    BMJ Case Rep

  10. MAHMOOD UF, Durairaj S
    Patent ductus arteriosus-related endocarditis: not just a theoretical risk.
    BMJ Case Rep. 2021;14.
    PubMed        


    Cell Biochem Biophys

  11. RAVI Y, Sai-Sudhakar CB, Kuppusamy P
    PTEN as a Therapeutic Target in Pulmonary Hypertension Secondary to Left-heart Failure: Effect of HO-3867 and Supplemental Oxygenation.
    Cell Biochem Biophys. 2021 Jun 16. pii: 10.1007/s12013-021-01010.
    PubMed         Abstract available


    Cells

  12. HAUTBERGUE T, Antigny F, Boet A, Haddad F, et al
    Right Ventricle Remodeling Metabolic Signature in Experimental Pulmonary Hypertension Models of Chronic Hypoxia and Monocrotaline Exposure.
    Cells. 2021;10.
    PubMed         Abstract available

  13. MONTAGNOLI TL, da Silva JS, Sudo SZ, Santos AD, et al
    ROCK Inhibition as Potential Target for Treatment of Pulmonary Hypertension.
    Cells. 2021;10.
    PubMed         Abstract available

  14. ROUBENNE L, Marthan R, Le Grand B, Guibert C, et al
    Hydrogen Sulfide Metabolism and Pulmonary Hypertension.
    Cells. 2021;10.
    PubMed         Abstract available


    Chin J Physiol

  15. WANG J, Li H, Xia T, Feng J, et al
    Pulmonary arterial hypertension and flavonoids: A role in treatment.
    Chin J Physiol. 2021;64:115-124.
    PubMed         Abstract available


    Compr Physiol

  16. MUKHERJEE D, Konduri GG
    Pediatric Pulmonary Hypertension: Definitions, Mechanisms, Diagnosis, and Treatment.
    Compr Physiol. 2021;11:2135-2190.
    PubMed         Abstract available


    Contact Dermatitis

  17. MALINAUSKIENE L, Slekyte G, Mowitz M, Isaksson M, et al
    Allergic contact dermatitis caused by isobornyl acrylate in two patients treated for idiopathic pulmonary arterial hypertension.
    Contact Dermatitis. 2020 May 20. doi: 10.1111/cod.13617.
    PubMed        


    Curr Opin Pulm Med

  18. KEEN JL, Thenappan T
    Shifting gears: the search for group 3 pulmonary hypertension treatment.
    Curr Opin Pulm Med. 2021 Jun 25. pii: 00063198-900000000-98952.
    PubMed         Abstract available


    Diagnostics (Basel)

  19. TORBICKI A
    Pulmonary Hypertension: Diagnosis and Management.
    Diagnostics (Basel). 2021;11.
    PubMed         Abstract available

  20. GIUCA A, Mihai C, Jurcut C, Gheorghiu AM, et al
    Screening for Pulmonary Hypertension in Systemic Sclerosis-A Primer for Cardio-Rheumatology Clinics.
    Diagnostics (Basel). 2021;11.
    PubMed         Abstract available


    Echocardiography

  21. MEMIC SANCAR K, Topel C, Turen S, Erturk M, et al
    An overlooked cause for reversible severe tricuspid regurgitation and pulmonary hypertension: Hibernating right ventricle.
    Echocardiography. 2021 Jun 29. doi: 10.1111/echo.15138.
    PubMed         Abstract available

  22. KAGAMI K, Harada T, Yamaguchi K, Kouno S, et al
    Association between lung ultrasound B-lines and exercise-induced pulmonary hypertension in patients with connective tissue disease.
    Echocardiography. 2021 Jun 29. doi: 10.1111/echo.15141.
    PubMed         Abstract available


    Entropy (Basel)

  23. TANG SY, Ma HP, Hung CS, Kuo PH, et al
    The Value of Heart Rhythm Complexity in Identifying High-Risk Pulmonary Hypertension Patients.
    Entropy (Basel). 2021;23.
    PubMed         Abstract available


    ESC Heart Fail

  24. JENEI C, Kadar R, Balogh L, Borbely A, et al
    Role of 3D echocardiography-determined atrial volumes in distinguishing between pre-capillary and post-capillary pulmonary hypertension.
    ESC Heart Fail. 2021 Jun 28. doi: 10.1002/ehf2.13496.
    PubMed         Abstract available

  25. ARVIDSSON M, Ahmed A, Bouzina H, Radegran G, et al
    Plasma proteoglycan prolargin in diagnosis and differentiation of pulmonary arterial hypertension.
    ESC Heart Fail. 2021;8:1230-1243.
    PubMed         Abstract available

  26. BOUZINA H, Radegran G, Butler O, Hesselstrand R, et al
    Longitudinal changes in risk status in pulmonary arterial hypertension.
    ESC Heart Fail. 2021;8:680-690.
    PubMed         Abstract available

  27. CAPEL A, Levy M, Szezepanski I, Malekzadeh-Milani S, et al
    Potts anastomosis in children with severe pulmonary arterial hypertension and atrial septal defect.
    ESC Heart Fail. 2021;8:326-332.
    PubMed         Abstract available

  28. KOUBSKY K, Tlaskal T, Chaloupecky V, Janousek J, et al
    How many types of circulation can a boy have during his life? A case of aortic stenosis with a borderline left ventricle.
    ESC Heart Fail. 2021;8:774-777.
    PubMed         Abstract available


    Eur J Cardiothorac Surg

  29. NAZARIO RA, Goldraich LA, Hastenteufel LCT, Santos ABS, et al
    Donor-recipient predicted heart mass ratio and right ventricular-pulmonary arterial coupling in heart transplant.
    Eur J Cardiothorac Surg. 2020 Nov 30. pii: 6227020. doi: 10.1093.
    PubMed         Abstract available


    Eur Respir J

  30. ULRICH S, Grunig E
    The patient tells it! The importance of patient's quality of life perception in pulmonary arterial hypertension risk assessment.
    Eur Respir J. 2021;57.
    PubMed        

  31. BOGAARD HJ, Sitbon O
    Initial triple therapy in pulmonary arterial hypertension: coming of age and rejuvenated.
    Eur Respir J. 2021;57.
    PubMed        

  32. HAARMAN MG, Levy M, Roofthooft MTR, Douwes JM, et al
    Upfront triple combination therapy in severe paediatric pulmonary arterial hypertension.
    Eur Respir J. 2021;57.
    PubMed         Abstract available

  33. AMSALLEM M, Sweatt AJ, Arthur Ataam J, Guihaire J, et al
    Targeted proteomics of right heart adaptation to pulmonary arterial hypertension.
    Eur Respir J. 2021;57.
    PubMed         Abstract available

  34. LEWIS RA, Armstrong I, Bergbaum C, Brewis MJ, et al
    EmPHasis-10 health-related quality of life score predicts outcomes in patients with idiopathic and connective tissue disease-associated pulmonary arterial hypertension: results from a UK multicentre study.
    Eur Respir J. 2021;57.
    PubMed         Abstract available

  35. MACIAS D, Moore S, Crosby A, Southwood M, et al
    Targeting HIF2alpha-ARNT hetero-dimerisation as a novel therapeutic strategy for pulmonary arterial hypertension.
    Eur Respir J. 2021;57.
    PubMed         Abstract available

  36. BORGESE M, Badesch D, Bull T, Chakinala M, et al
    EmPHasis-10 as a measure of health-related quality of life in pulmonary arterial hypertension: data from PHAR.
    Eur Respir J. 2021;57.
    PubMed         Abstract available


    Front Cell Dev Biol

  37. ZHAO Q, Song P, Zou MH
    AMPK and Pulmonary Hypertension: Crossroads Between Vasoconstriction and Vascular Remodeling.
    Front Cell Dev Biol. 2021;9:691585.
    PubMed         Abstract available


    Front Vet Sci

  38. TANGMAHAKUL N, Makoom P, Surachetpong SD
    Assessment of Platelet and Plasma Serotonin in Canine Pulmonary Hypertension Secondary to Degenerative Mitral Valve Disease.
    Front Vet Sci. 2021;8:695492.
    PubMed         Abstract available


    Int J Cardiovasc Imaging

  39. KAMIDE H, Kato S, Hayakawa K, Fukui K, et al
    Impairment of right ventricular strain evaluated by cardiovascular magnetic resonance feature tracking in patients with interstitial lung disease.
    Int J Cardiovasc Imaging. 2021;37:1073-1083.
    PubMed         Abstract available


    Int J Chron Obstruct Pulmon Dis

  40. SANGANI R, Ghio A, Culp S, Patel Z, et al
    Combined Pulmonary Fibrosis Emphysema: Role of Cigarette Smoking and Pulmonary Hypertension in a Rural Cohort.
    Int J Chron Obstruct Pulmon Dis. 2021;16:1873-1885.
    PubMed         Abstract available


    Int J Mol Sci

  41. WEST JD, Austin ED, Rizzi EM, Yan L, et al
    KCNK3 Mutation Causes Altered Immune Function in Pulmonary Arterial Hypertension Patients and Mouse Models.
    Int J Mol Sci. 2021;22.
    PubMed         Abstract available


    J Clin Med

  42. BAZ L, Rossberg M, Grun K, Kretzschmar D, et al
    Serum Liberation of Fetal Fibronectin Variants in Patients with Pulmonary Hypertension: ED-A(+) Fn as Promising Novel Biomarker of Pulmonary Vascular and Right Ventricular Myocardial Remodeling.
    J Clin Med. 2021;10.
    PubMed         Abstract available


    J Clin Rheumatol

  43. HABIB P, Podgorski M, Adorini K, Brown M, et al
    First Reported Case of Pulmonary Arterial Hypertension Secondary to Tofacitinib Treatment for Undifferentiated Arthritis.
    J Clin Rheumatol. 2021;27:e136-e138.
    PubMed        


    J Patient Rep Outcomes

  44. CURRIE B, Davies E, Beaudet A, Stassek L, et al
    Symptoms, impacts, and suitability of the Pulmonary Arterial Hypertension - Symptoms and Impact (PAH-SYMPACT) questionnaire in patients with chronic thromboembolic pulmonary hypertension (CTEPH): a qualitative interview study.
    J Patient Rep Outcomes. 2021;5:51.
    PubMed         Abstract available


    J Pediatr

  45. ADAIR JD, Kelly B, Schilling D, Parkhotyuk K, et al
    Pulmonary Function Tests in Very Low Birth Weight Infants Screened for Pulmonary Hypertension: A Pilot Study.
    J Pediatr. 2021 Jun 25. pii: S0022-3476(21)00628.
    PubMed         Abstract available


    J Thorac Cardiovasc Surg

  46. WONG MKH, Hsin MK
    Commentary: The perfidious left ventricle in pulmonary hypertension.
    J Thorac Cardiovasc Surg. 2021 Jun 24. pii: S0022-5223(21)00890.
    PubMed        

  47. KLAPPER JA
    Commentary: Respect idiopathic pulmonary hypertension...or urine trouble.
    J Thorac Cardiovasc Surg. 2021 Jun 23. pii: S0022-5223(21)00896.
    PubMed        

  48. FECZKO AF, Raja S
    Commentary: The pressure to treat pulmonary artery hypertension.
    J Thorac Cardiovasc Surg. 2021;161:e435-e436.
    PubMed        

  49. DATE H
    Commentary: A new treatment strategy for pulmonary arterial hypertension.
    J Thorac Cardiovasc Surg. 2021;161:e436-e437.
    PubMed        

  50. ISHIBASHI N, Jonas RA
    Commentary: Nitric oxide: An important contributor to neuroprotection during pediatric cardiac surgery.
    J Thorac Cardiovasc Surg. 2020 Jan 7. pii: S0022-5223(20)30032.
    PubMed        


    Kyobu Geka

  51. TAKEUCHI H, Achiwa I, Takei T, Kondo R, et al
    [Pulmonary Artery Replacement in a Patient with Pulmonary Artery Dissection Associated with Pulmonary Hypertension and Single Ventricle:Report of a Case].
    Kyobu Geka. 2021;74:539-542.
    PubMed         Abstract available


    Lancet Respir Med

  52. NATHAN SD, Waxman A, Rajagopal S, Case A, et al
    Inhaled treprostinil and forced vital capacity in patients with interstitial lung disease and associated pulmonary hypertension: a post-hoc analysis of the INCREASE study.
    Lancet Respir Med. 2021 Jun 29. pii: S2213-2600(21)00165.
    PubMed         Abstract available


    N Engl J Med

  53. YANG P, Bocobo GA, Yu PB
    Sotatercept for Pulmonary Arterial Hypertension.
    N Engl J Med. 2021;385:92-93.
    PubMed        


    Pharmacol Ther

  54. SHARMA S, Stansbury R, Hackett B, Fox H, et al
    Sleep apnea and pulmonary hypertension: A riddle waiting to be solved.
    Pharmacol Ther. 2021;227:107935.
    PubMed         Abstract available


    Pulm Circ

  55. RASHIDI F, Mousavi-Aghdas SA, Kaymaz C
    Is the maternal risk of pregnancy acceptable in patients with moderate pulmonary hypertension?
    Pulm Circ. 2021;11:20458940211023697.
    PubMed        

  56. MENON DP, Qi G, Kim SK, Moss ME, et al
    Vascular cell-specific roles of mineralocorticoid receptors in pulmonary hypertension.
    Pulm Circ. 2021;11:20458940211025240.
    PubMed         Abstract available

  57. SITAPARA R, Sugarragchaa C, Zisman LS
    SU5416 plus hypoxia but not selective VEGFR2 inhibition with cabozantinib plus hypoxia induces pulmonary hypertension in rats: potential role of BMPR2 signaling.
    Pulm Circ. 2021;11:20458940211021528.
    PubMed         Abstract available


    Respir Care

  58. GIANNI S, Carroll RW, Kacmarek RM, Berra L, et al
    Inhaled Nitric Oxide Delivery Systems for Mechanically Ventilated and Nonintubated Patients: A Review.
    Respir Care. 2021;66:1021-1028.
    PubMed         Abstract available


    Respir Med Res

  59. ESNAUD R, Gagnadoux F, Beurnier A, Berrehare A, et al
    The association between sleep-related breathing disorders and pre-capillary pulmonary hypertension: A chicken and egg question.
    Respir Med Res. 2021;80:100835.
    PubMed         Abstract available


    Rev Port Cardiol

  60. CALE R, Ferreira F, Pereira AR, Repolho D, et al
    Safety and efficacy of balloon pulmonary angioplasty in a Portuguese pulmonary hypertension expert center.
    Rev Port Cardiol. 2021 Jun 25. pii: S0870-2551(21)00194.
    PubMed         Abstract available


    Rheumatol Int

  61. BOURNIA VK, Kallianos A, Panopoulos S, Gialafos E, et al
    Cardiopulmonary exercise testing and prognosis in patients with systemic sclerosis without baseline pulmonary hypertension: a prospective cohort study.
    Rheumatol Int. 2021 Jun 29. pii: 10.1007/s00296-021-04937.
    PubMed         Abstract available


    Rheumatology (Oxford)

  62. GIGANTE A, Villa A, Rosato E
    Laser speckle contrast analysis predicts major vascular complications and mortality of patients with systemic sclerosis.
    Rheumatology (Oxford). 2021;60:1850-1857.
    PubMed         Abstract available


    Semin Thorac Cardiovasc Surg

  63. SEAMAN CS, d'Udekem Y, Jones BO, Brizard CPR, et al
    Augmentation of Pulmonary Arterial Growth in Single Ventricle Patients by Interim Selective Shunts.
    Semin Thorac Cardiovasc Surg. 2021;33:483-489.
    PubMed         Abstract available


    Vascul Pharmacol

  64. MADONNA R, Fabiani S, Morganti R, Forniti A, et al
    Exercise-induced pulmonary hypertension in HIV patients: Association with poorer clinical and immunological status.
    Vascul Pharmacol. 2021 Jun 25:106888. doi: 10.1016/j.vph.2021.106888.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: